Strategic Clinical Project Management: Principles and Practical Applications
In the project management world, there are resources to help you manage almost any project. There are many processes, forms, and computer applications that will help you complete your project. But what is the best way to use these tools? What is the order that would make them most impactful? More specifically, how do you apply these tools to a clinical trial environment, where the goals and expected outcomes are much different and risks of failure are much higher?
The answer to these questions and more lies in being strategic. A review of case studies from failed clinical projects shows that the most costly decisions happen at the beginning. When you strategize and keep the most critical factors in mind, you will set yourself up for greater success, and this session will start you on that path.
In this interactive, 90-minute course, you will learn:
- The five key differences between clinical project management and general project management: implementing key steps to ensure success
- Project initiation: Ask the “4 Critical Strategic Questions”
- The definition of strategic project management – are you a strategic or tactical project manager?
- Leadership, strategy and oversight: learn the three domains of strategic project management
- Project maintenance: why risk management, team building, and team leadership are so critical
- Project closure: measure success with definable outcomes and data
This course will be of benefit to anyone involved in single project or program management on a global or domestic scale. Additionally, this course is designed to provide practical tips to those who need to be able to lead a cross-functional project management teams in order to implement clinical trials.
Lydia Dyett joined Halloran Consulting Group in 2013. She has more than 17 years of experience in drug research and development, specifically focusing on cardio-renal and oncology indications from both the CRO and Sponsor side of clinical development. Lydia’s most recent trial experience has afforded her experience in international clinical development and pediatric medicine.
Prior to joining Halloran, Lydia worked primarily in pain, gastro-intestinal and cardio-renal therapeutic areas. She helped adapt new patient reported outcome solutions in OBD and hyponatremia. Working with subject matter experts in regulatory and PRO solutions, Lydia aided in the development of Clinical Global Impression (CGI) scale for dilutional hyponatremia. Lydia also worked on novel research in atrial fibrillation, aiming to integrate 24-hour Phase 1 trial procedures into a standard of care paradigm that releases patients from treatment within 2-hours.
Laurie Halloran, BSN founded Halloran Consulting Group in 1998. With over 25 years of experience in clinical affairs management with contract research organizations and biotechnology companies, Laurie is recognized as an industry expert in improving the organizational effectiveness of clinical research programs with a specialty in gap analysis and strategic planning. Laurie has managed 25+ clinical trials from Phase I to Phase III for both emerging and established companies and has managed operational budgets of up to $24 MM.
Prior to founding Halloran, Laurie spent 10 years at PAREXEL International where she developed worldwide training capabilities with the clinical operations group. She has also established clinical operations at OXiGENE and Antigenics.
Laurie is an adjunct professor at Boston University Medical School and lectures at the Tufts Center for Drug Development Post-Graduate program. She has previously taught at George Washington University and Harvard University. In 2010, Laurie was selected as one of the 100 Most Inspiring People in Life Science by PharmaVoice and in 2009 was awarded Clinical Researcher of the Year by the New England Chapter of the Association of Clinical Research Professionals.